Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
… of patients, and 12.5% had CNS metastases. Treatments included pembrolizumab (71.9%), nivolumab (21.9%) and durvalumab (6.3%); 71.9% receive…
…Background and Importance PCSK9 inhibitors (alirocumab and evolocumab) effectively reduce Low-density lipoprotein (LDLc) and cardiova…
… abnormalities (5.4%), muscular weakness (1.8%), Comorbidities: chronic kidney failure (44.6%), heart failure (41.1%) diabetes (37.5%). acute kidney f…
…f which 50% (n=1) required dose reduction. 27 patients received meropenem, of which 18% (n=5) required dose reduction and 7% (n=2) requir…
… hours of treatment, potassium levels decreased in 60 patients. Hyperkalaemia persisted in 45 patients at 24 hours and in only 15 at 48 hours…
…ype with functional decline. Antifibrotic therapy, particularly nintedanib, has significantly improved management by slowing forced vital …
… patients were included (mean age 58.5±13.2 years; 62.7% male). Tezepelumab was used as first-line in 25/52 (48.1%), second-line in 15/52 (…
…nd dose reductions in 20%.Conclusion and Relevance Weight-based pembrolizumab dosing achieved pCR and safety results consistent with those fr…
…ication-related falls. The screening tool should be tested in a Danish hospital. Potentially through integration in the electronic health recor…
…allogeneic haematopoietic stem cell transplantation(allo-HSCT). Ruxolitinib is effective in refractory cases, but real-world safety data ar…
…Dictionary for Regulatory Activities v27.0) in association with daptomycin. The disproportionality analysis was conducted using IBM SPSS M…
…tions and had 1.1 PIMs. The most frequent PIM drug classes were proton pump inhibitors (28%), benzodiazepines (16%), and antipsychotics (11%). Among t…